BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17961071)

  • 21. Protein disulfide isomerase P5-immunopositive inclusions in patients with Alzheimer's disease.
    Honjo Y; Horibe T; Torisawa A; Ito H; Nakanishi A; Mori H; Komiya T; Takahashi R; Kawakami K
    J Alzheimers Dis; 2014; 38(3):601-9. PubMed ID: 24037032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of s-nitrosylation and s-glutathionylation of protein disulphide isomerase in protein misfolding and neurodegeneration.
    Halloran M; Parakh S; Atkin JD
    Int J Cell Biol; 2013; 2013():797914. PubMed ID: 24348565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.
    Nakamura T; Oh CK; Zhang X; Lipton SA
    Free Radic Biol Med; 2021 Aug; 172():562-577. PubMed ID: 34224817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
    Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine 343 in the substrate binding domain is the primary S-Nitrosylated site in protein disulfide isomerase.
    Ogura J; Ruddock LW; Mano N
    Free Radic Biol Med; 2020 Nov; 160():103-110. PubMed ID: 32768572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Protein S-Nitrosylation in Protein Misfolding-Associated Diseases.
    Ju YJ; Lee HW; Choi JW; Choi MS
    Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders.
    Chung KK
    Neurosignals; 2006-2007; 15(6):307-13. PubMed ID: 17901712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant protein s-nitrosylation in neurodegenerative diseases.
    Nakamura T; Tu S; Akhtar MW; Sunico CR; Okamoto S; Lipton SA
    Neuron; 2013 May; 78(4):596-614. PubMed ID: 23719160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.
    Nakamura T; Cho DH; Lipton SA
    Exp Neurol; 2012 Nov; 238(1):12-21. PubMed ID: 22771760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-synuclein oligomerization in manganese-induced nerve cell injury in brain slices: a role of NO-mediated S-nitrosylation of protein disulfide isomerase.
    Xu B; Jin CH; Deng Y; Liu W; Yang TY; Feng S; Xu ZF
    Mol Neurobiol; 2014 Dec; 50(3):1098-110. PubMed ID: 24777576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
    Nakamura T; Lipton SA
    Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oxidoreductase behavior of protein disulfide isomerase impedes fold maturation of endoplasmic reticulum-processed proteins in the pivotal structure-coupled step of oxidative folding: implications for subcellular protein trafficking.
    Gonzalez V; Pal R; Narayan M
    Biochemistry; 2010 Jul; 49(29):6282-9. PubMed ID: 20568731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; VĂ©csei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide.
    Zai A; Rudd MA; Scribner AW; Loscalzo J
    J Clin Invest; 1999 Feb; 103(3):393-9. PubMed ID: 9927500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical stress on protein disulfide isomerases and inhibition of their functions.
    Imaoka S
    Int Rev Cell Mol Biol; 2011; 290():121-66. PubMed ID: 21875564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein disulfide isomerase mediates glutathione depletion-induced cytotoxicity.
    Okada K; Fukui M; Zhu BT
    Biochem Biophys Res Commun; 2016 Aug; 477(3):495-502. PubMed ID: 27317486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDI Knockdown Inhibits Seizure Activity in Acute Seizure and Chronic Epilepsy Rat Models via
    Jeon AR; Kim JE
    Front Cell Neurosci; 2018; 12():438. PubMed ID: 30524244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging role of protein-protein transnitrosylation in cell signaling pathways.
    Nakamura T; Lipton SA
    Antioxid Redox Signal; 2013 Jan; 18(3):239-49. PubMed ID: 22657837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isomerase and chaperone activities of protein disulfide isomerase are both required for its function as a foldase.
    Wang CC
    Biochemistry (Mosc); 1998 Apr; 63(4):407-12. PubMed ID: 9556523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.